Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States

Archives of Pediatrics and Adolescent Medicine

Volumn 157, Issue 5, 2003, Pages 443-448

  Marshall, Gary S ^a   Stout, Gordon G ^a   Jacobs, Richard F ^b   Schutze, Gordon E ^b   Paxton, Helene ^g   Buckingham, Steven C ^c   DeVincenzo, John P ^c   Jackson, Mary Anne ^d   San Joaquin, Venusto H ^e   Standaert, Steven M ^h   Woods, Charles R ^f   Antony, Joan ^g   Leonard, Michael ^h   Dumler, J Stephen ⁱ  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g PanBio InDx Inc   (United States)

^h VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; FEVER; GEOGRAPHY; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RICKETTSIA RICKETTSII; RICKETTSIOSIS; SEROPREVALENCE; UNITED STATES;

ADOLESCENT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SEROEPIDEMIOLOGIC STUDIES; SOUTHEASTERN UNITED STATES;

EID: 0037740593     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.157.5.443     Document Type: Article

References (32)

1. Marshall GS. The emergence of tick-borne diseases [editorial]. Pediatr Ann. 2002;31:160-161.
2. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg. 2000;63:21-26.
3. Buckingham SC. Rocky Mountain spotted fever: a review for the pediatrician. Pediatr Ann. 2002;31:163-168.
4. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488.
5. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52:405-413.
6. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20:1118-1121.
7. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001;184:1437-1444.
8. Loving SM, Smith AB, DiSalvo AF, Burgdorfer W. Distribution and prevalence of spotted fever group rickettsiae in ticks from South Carolina, with an epidemiological survey of persons bitten by infected ticks. Am J Trop Med Hyg. 1978;27:1255-1260.
9. Marx RS, McCall CE, Abramson JS, Harlan JE. Rocky Mountain spotted fever: serological evidence of previous subclinical infection in children. AJDC. 1982;136;16-18.
10. Wilfert CM, MacCormack JN, Kleeman K, et al. The prevalence of antibodies to Rickettsia rickettsiin an area endemic for Rocky Mountain spotted fever. J Infect Dis. 1985;151:823-831.
11. Taylor JP, Tanner WB, Rawlings JA, et al. Serological evidence of subclinical Rocky Mountain spotted fever in Texas. J Infect Dis. 1985;151:367-369.
12. Sanchez JL, Candler WH, Fishbein DB, et al. A cluster of tick-borne infections: association with military training and asymptomatic infections due to Rickettsia rickettsii. Trans R Soc Trop Med Hyg. 1992;86:321-325.
13. Yevich SJ, Sanchez JL, DeFraites RF, et al. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis. 1995;171:1266-1273.
14. Hilton E, DeVoti J, Benach JL, et al. Seroprevalence and seroconversion for tickborne diseases in a high-risk population in the northeast United States. Am J Med. 1999;106:404-409.
15. Marshall GS, Jacobs RF, Schutze GE, et al. Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med. 2002;156:166-170.
16. Marshall GS, for the Tick-Borne Infections in Children Study Group. Rickettsia typhi seroprevalence among children in the southeast United States. Pediatr Infect Dis J. 2000;19:1103-1104.
17. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(No. RR-10):1-55.
18. Gross EM, Goldwasser RA, Bearman JE, et al. Rickettsial antibody prevalence in southern Israel: IgG antibodies to Coxiella burnetii, Rickettsia typhi, and spotted fever group rickettsiae among urban- and rural-dwelling and Bedouin women. Am J Trop Med Hyg. 1983;32:1387-1391.
19. Yagupsky P, Sarov B, Naggan L, Sarov I, Avy K, Goldwasser R. The prevalence of IgG antibodies to spotted-fever group rickettsiae among urban and rural dwelling children in southern Israel. Scand J Infect Dis. 1990;22:19-23.
20. Ruiz-Beltran R, Herrero-Herrero JI, Martin-Sanchez AM, Martin-Gonzalez JA. Prevalence of antibodies to Rickettsia conorii, Coxiella burnetii, and Rickettsia typhi in Salamanca province (Spain): serosurvey in the human population. Eur J Epidemiol. 1990;6:293-299.
21. Hechemy KE. The immunoserology of rickettsiae, In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM, eds. Manual of Clinical Laboratory Immunology. 4th ed. Washington, DC: American Society for Microbiology; 1992:667-675.
22. McDade JE, Newhouse VF. Natural history of Rickettsia rickettsii. Annu Rev Microbiol. 1986;40:287-309.
23. Dawson JE, Fishbein DB, Eng TR, Redus MA, Green NR. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: kinetics and specificity. J Infect Dis. 1990;162:91-95.
24. Sexton DJ, Corey GR, Carpenter C, et al. Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report. Emerg Infect Dis. 1998;4:311-316.
25. Carpenter CF, Gandhi TK, Kong LK, et al. The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. J Infect Dis. 1999;180:900-903.
26. Kelly DJ, Osterman JV, Stephenson EH. Rocky Mountain spotted fever in areas of high and low prevalence: survey for canine antibodies to spotted fever rickettsiae. Am J Vet Res. 1982;43:1429-1431.
27. Breitschwerdt EB, Moncol DJ, Corbett WT, et al. Antibodies to spotted fevergroup rickettsiae in dogs in North Carolina. Am J Vet Res. 1987;48:1436-1440.
28. Schubert JH. Serologic titers in rickettsial infection as affected by antibiotic treatment. Public Health Lab. 1952;10:38-41.
29. Clements ML, Dumler JS, Fiset P, Wisseman CL, Snyder MJ, Levine MM. Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test. J Infect Dis. 1983;148:876-880.
30. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States. Emerg Infect Dis. 1999;5:635-642.
31. Salgo MP, Telzak EE, Currie B, et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med. 1988;318:1345-1348.
32. Jones TF, Craig AS, Paddock CD, et al. Family cluster of Rocky Mountain spotted fever. Clin Infect Dis. 1999;28:853-859.